Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases
- PMID: 5189
Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases
Abstract
Four cultured mammalian cell lines, differing in intrinsic resistance to methotrexate over a 70-fold range, have been compared with respect to several biochemical factors that might influence response to the drug. Cellular activity of the enzymes dihydrofolate reductase and thymidylate synthetase and the total levels of folate cofactors did not vary by more than a factor of 2 among the cell lines. All the cell types were able to transport extracellular methotrexate efficiently across the cell membrane, and at comparable rates. A kinetic study of highly purified dihydrofolate reductases from the four sources revealed small differences in the Km values for dihydrofolate and reduced nicotinamide adenine dinucleotide phosphate. A study was made of the inhibition of the four dihydrofolate reductases by methotrexate, and Ki values were obtained by fitting the Zone B equation of Goldstein (Goldstein, A., J. Gen. Physiol., 27: 529-580, 1944) to the resulting data. Values Ki determined by this method correlated with intrinsic resistance of the cell lines and showed a 25-fold range from the most sensitive to the most resistant line. It is concluded that the response of a cell to methotrexate is significantly influenced by the dissociation constant of its dihydrofolate reductase-methotrexate complex.
Similar articles
-
Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.Cancer Res. 1976 Jul;36(7 PT 1):2442-9. Cancer Res. 1976. PMID: 1277151
-
Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.Cancer Res. 1983 Nov;43(11):5286-92. Cancer Res. 1983. PMID: 6225514
-
Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.Cancer Res. 1984 Jun;44(6):2325-30. Cancer Res. 1984. PMID: 6609765
-
Biochemical factors in the selectivity of leucovorin rescue: selective inhibition of leucovorin reactivation of dihydrofolate reductase and leucovorin utilization in purine and pyrimidine biosynthesis by methotrexate and dihydrofolate polyglutamates.NCI Monogr. 1987;(5):17-26. NCI Monogr. 1987. PMID: 2448654 Review.
-
Methotrexate resistant cells as targets for selective chemotherapy.Adv Enzyme Regul. 1985;24:3-11. doi: 10.1016/0065-2571(85)90066-4. Adv Enzyme Regul. 1985. PMID: 3915186 Review.
Cited by
-
An enzyme inhibition assay for 2,4-diamino-5-(3'4'-dichlorophenyl)-6-methylpyrimidine (DDMP,NSC 19494).J Clin Pathol. 1977 Dec;30(12):1154-7. doi: 10.1136/jcp.30.12.1154. J Clin Pathol. 1977. PMID: 604362 Free PMC article.
-
Role of thymidylate synthetase activity in development of methotrexate cytotoxicity.Proc Natl Acad Sci U S A. 1979 Nov;76(11):5924-8. doi: 10.1073/pnas.76.11.5924. Proc Natl Acad Sci U S A. 1979. PMID: 160558 Free PMC article.
-
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition.Cancer Res. 2009 Jul 1;69(13):5467-74. doi: 10.1158/0008-5472.CAN-08-4979. Epub 2009 Jun 23. Cancer Res. 2009. PMID: 19549896 Free PMC article.
-
Mutations in the reduced-folate carrier affect protein localization and stability.Biochem J. 2000 Mar 1;346 Pt 2(Pt 2):509-18. Biochem J. 2000. PMID: 10677373 Free PMC article.
-
The former annotated human pseudogene dihydrofolate reductase-like 1 (DHFRL1) is expressed and functional.Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15157-62. doi: 10.1073/pnas.1103605108. Epub 2011 Aug 26. Proc Natl Acad Sci U S A. 2011. PMID: 21876184 Free PMC article.